{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:08:08Z","timestamp":1761498488497,"version":"build-2065373602"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005968","name":"Leukemia Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004414","name":"International Monetary Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.beha.2012.03.001","type":"journal-article","created":{"date-parts":[[2012,5,4]],"date-time":"2012-05-04T17:54:24Z","timestamp":1336154064000},"page":"143-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Flipping the cyclin D1 switch in mantle cell lymphoma"],"prefix":"10.1016","volume":"25","author":[{"given":"Zainul","family":"Hasanali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot","family":"Epner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2012.03.001_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.2008.07124.x","article-title":"Advances in the understanding of mantle cell lymphoma","volume":"142","author":"Jares","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2012.03.001_bib2","first-page":"314","article-title":"Familial lymphoid neoplasms in patients with mantle cell lymphoma","volume":"89","author":"Tort","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2012.03.001_bib3","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood.V83.7.1871.1871","article-title":"Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas","volume":"83","author":"Rimokh","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.03.001_bib4","first-page":"7","article-title":"Control of the G1\/S transition","volume":"29","author":"Reed","year":"1997","journal-title":"Cancer Surv"},{"key":"10.1016\/j.beha.2012.03.001_bib5","doi-asserted-by":"crossref","first-page":"9754","DOI":"10.1074\/jbc.M212088200","article-title":"The cyclin D1-dependent kinase associates with the pre-replication complex and modulates RB.MCM7 binding","volume":"278","author":"Gladden","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.beha.2012.03.001_bib6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molmed.2004.02.005","article-title":"The activities of cyclin D1 that drive tumorigenesis","volume":"10","author":"Ewen","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.beha.2012.03.001_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0896-6273(94)90276-3","article-title":"Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death","volume":"12","author":"Freeman","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.beha.2012.03.001_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.thj.6200025","article-title":"Cyclin D1 expression in patients with multiple myeloma","volume":"1","author":"Troussard","year":"2000","journal-title":"Hematol J"},{"key":"10.1016\/j.beha.2012.03.001_bib9","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1182\/blood.V96.3.808","article-title":"The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies","volume":"96","author":"Willis","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.03.001_bib10","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.4049\/jimmunol.160.10.4896","article-title":"3\u2032 IgH enhancer elements shift synergistic interactions during B cell development","volume":"160","author":"Ong","year":"1998","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.beha.2012.03.001_bib11","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1084\/jem.20072102","article-title":"Transvection mediated by the translocated cyclin D1 locus in mantle cell lymphoma","volume":"205","author":"Liu","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.beha.2012.03.001_bib12","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1101\/gad.1072303","article-title":"The beta-globin locus control region (LCR) functions primarily by enhancing the transition from transcription initiation to elongation","volume":"17","author":"Sawado","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.beha.2012.03.001_bib13","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1182\/blood-2004-02-0483","article-title":"Cyclin D1 activation in B-cell malignancy: association with changes in histone acetylation, DNA methylation, and RNA polymerase II binding to both promoter and distal sequences","volume":"104","author":"Liu","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.03.001_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0959-437X(99)80024-0","article-title":"DNA methylation and chromatin modification","volume":"9","author":"Ng","year":"1999","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.beha.2012.03.001_bib15","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2012.03.001_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0074-7696(03)01002-7","article-title":"Genomic domains and regulatory elements operating at the domain level","volume":"226","author":"Razin","year":"2003","journal-title":"Int Rev Cytol"},{"key":"10.1016\/j.beha.2012.03.001_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jcb.10286","article-title":"Chromatin remodeling, histone modifications, and DNA methylation-how does it all fit together?","volume":"87","author":"Geiman","year":"2002","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.beha.2012.03.001_bib18","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.beha.2012.03.001_bib19","doi-asserted-by":"crossref","first-page":"28787","DOI":"10.1074\/jbc.274.40.28787","article-title":"Transcriptional regulation of rat cyclin D1 gene by CpG methylation status in promoter region","volume":"274","author":"Kitazawa","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.beha.2012.03.001_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)81761-4","article-title":"Do LCRs open chromatin domains?","volume":"95","author":"Higgs","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.beha.2012.03.001_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11864-007-0047-8","article-title":"The epigenetics of mantle cell lymphoma","volume":"8","author":"Yu","year":"2007","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.beha.2012.03.001_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era","volume":"117","author":"Perez-Galan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.03.001_bib23","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1523\/JNEUROSCI.17-16-06122.1997","article-title":"Nerve growth factor induces transcription of the p21 WAF1\/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor","volume":"17","author":"Yan","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.beha.2012.03.001_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/gcc.2870070205","article-title":"PRAD1\/cyclin D1 proto-oncogene: genomic organization, 5\u2032 DNA sequence, and sequence of a tumor-specific rearrangement breakpoint","volume":"7","author":"Motokura","year":"1993","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.beha.2012.03.001_bib25","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1182\/blood-2006-08-039859","article-title":"Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival","volume":"109","author":"Wiestner","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.03.001_bib26","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2008-03-142182","article-title":"Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma","volume":"112","author":"Chen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.03.001_bib27","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.cell.2007.02.007","article-title":"Paramutation: from maize to mice","volume":"128","author":"Chandler","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.beha.2012.03.001_bib28","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nrg1378","article-title":"Chromatin conversations: mechanisms and implications of paramutation","volume":"5","author":"Chandler","year":"2004","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.beha.2012.03.001_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng1162","article-title":"Trans allele methylation and paramutation-like effects in mice","volume":"34","author":"Herman","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2012.03.001_bib30","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1093\/genetics\/148.4.1973","article-title":"Paramutation of the r1 locus of maize is associated with increased cytosine methylation","volume":"148","author":"Walker","year":"1998","journal-title":"Genetics"},{"key":"10.1016\/j.beha.2012.03.001_bib31","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(00)80161-0","article-title":"Interchromosomal transfer of epigenetic states in Ascobolus: transfer of DNA methylation is mechanistically related to homologous recombination","volume":"86","author":"Colot","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.beha.2012.03.001_bib32","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2011-11-391474","article-title":"Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma","author":"Kridel","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.03.001_bib33","doi-asserted-by":"crossref","first-page":"7245","DOI":"10.1128\/MCB.01085-08","article-title":"Genotoxic stress-induced cyclin D1 phosphorylation and proteolysis are required for genomic stability","volume":"28","author":"Pontano","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.beha.2012.03.001_bib34","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/leu.2008.213","article-title":"Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2","volume":"22","author":"Klier","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2012.03.001_bib35","first-page":"1373","article-title":"Crosstalk between cyclins D1 and D3 in mantle cell level at the transcriptional and postranscriptional levels","volume":"118","author":"Stuart","year":"2011","journal-title":"ASH Annu Meet Abstr"},{"key":"10.1016\/j.beha.2012.03.001_bib36","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1200\/JCO.2005.08.133","volume":"23","author":"Lenz","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2012.03.001_bib37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3109\/10428191003699860","article-title":"High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone","volume":"51","author":"Kamel","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2012.03.001_bib38","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/cncr.25582","article-title":"Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma","volume":"117","author":"Musolino","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2012.03.001_bib39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1586\/14737140.8.4.535","article-title":"Cladribine in indolent non-Hodgkin's lymphoma","volume":"8","author":"Sigal","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.beha.2012.03.001_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0006-2952(02)01486-7","article-title":"The effects of cladribine and fludarabine on DNA methylation in K562 cells","volume":"65","author":"Wyczechowska","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.beha.2012.03.001_bib41","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4161\/cbt.3.11.1308","article-title":"Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy","volume":"3","author":"Gowher","year":"2004","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.beha.2012.03.001_bib42","doi-asserted-by":"crossref","first-page":"11797","DOI":"10.1073\/pnas.91.25.11797","article-title":"Toxicity of 5-aza-2\u2032-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation","volume":"91","author":"Juttermann","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2012.03.001_bib43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.beha.2011.02.009","article-title":"Rituximab resistance","volume":"24","author":"Rezvani","year":"2011","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.beha.2012.03.001_bib44","doi-asserted-by":"crossref","DOI":"10.1158\/1541-7786.MCR-11-0154","article-title":"Direct effect of rituximab in B-cell-derived lymphoid neoplasias: mechanism, regulation, and perspectives","author":"Bezombes","year":"2011","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.beha.2012.03.001_bib45","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1200\/JCO.2005.04.164","article-title":"Effect of single-agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research (SAKK)","volume":"23","author":"Ghielmini","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2012.03.001_bib46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/cncr.23537","article-title":"Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central Cancer Treatment Group","volume":"113","author":"Inwards","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2012.03.001_bib47","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1158\/1078-0432.CCR-10-3412","article-title":"Vorinostat-induced apoptosis in mantle cell lymphoma is mediated by acetylation of proapoptotic BH3-only gene promoters","volume":"17","author":"Xargay-Torrent","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2012.03.001_bib48","first-page":"2440","article-title":"Epigenetic modulation of Alemtuzumab mediated antileukemia effects and resistance in T-cell prolymphocytic leukemia","volume":"118","author":"Sharma","year":"2011","journal-title":"ASH Annu Meet Abstr"},{"key":"10.1016\/j.beha.2012.03.001_bib49","first-page":"471","article-title":"Advances in the understanding of mechanisms and therapeutic use of bortezomib","volume":"12","author":"Mujtaba","year":"2011","journal-title":"Discov Med"},{"key":"10.1016\/j.beha.2012.03.001_bib50","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3109\/10428194.2011.584253","article-title":"Curcumin nanodisk-induced apoptosis in mantle cell lymphoma","volume":"52","author":"Singh","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2012.03.001_bib51","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2002-05-1320","article-title":"Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis","volume":"101","author":"Bharti","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.03.001_bib52","doi-asserted-by":"crossref","first-page":"8852","DOI":"10.1038\/sj.onc.1206048","article-title":"Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation","volume":"21","author":"Mukhopadhyay","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.beha.2012.03.001_bib53","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bcp.2005.04.043","article-title":"Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1\/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma","volume":"70","author":"Shishodia","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.beha.2012.03.001_bib54","first-page":"264","article-title":"Cdk4\/6 inhibitor PD 0332991 demonstrates cell cycle inhibition via FLT-PET imaging and tissue analysis in patients with recurrent mantle cell lymphoma","volume":"112","author":"Leonard","year":"2008","journal-title":"ASH Annu Meet Abstr"},{"key":"10.1016\/j.beha.2012.03.001_bib55","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1182\/blood-2010-11-314708","article-title":"The combination of bendamustine, bortezomib, and rituximab for patients with relapsed\/refractory indolent and mantle cell non-Hodgkin lymphoma","volume":"117","author":"Friedberg","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.03.001_bib56","unstructured":"Leonard JP. Phase I trial of PD 0332991 plus bortezomib in patients with relapsed mantle cell lymphoma 2010."},{"key":"10.1016\/j.beha.2012.03.001_bib57","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3324\/haematol.2009.013870","article-title":"Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma","volume":"95","author":"Wozniak","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2012.03.001_bib58","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2005-11-026344","article-title":"Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells","volume":"110","author":"Kawamata","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.03.001_bib59","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/j.seminhematol.2011.03.008","article-title":"Treatment of elderly patients with mantle cell lymphoma","volume":"48","author":"Kluin-Nelemans","year":"2011","journal-title":"Semin Hematol"},{"key":"10.1016\/j.beha.2012.03.001_bib60","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3109\/10428194.2011.575489","article-title":"Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma","volume":"52","author":"Spurgeon","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2012.03.001_bib61","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.semcancer.2011.09.008","article-title":"New molecular targets in mantle cell lymphoma","volume":"21","author":"Parekh","year":"2011","journal-title":"Semin Cancer Biol"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692612000278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692612000278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:04:26Z","timestamp":1761498266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692612000278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1521692612000278"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2012.03.001","relation":{},"ISSN":["1521-6926"],"issn-type":[{"type":"print","value":"1521-6926"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flipping the cyclin D1 switch in mantle cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2012.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}